e-learning
resources
Virtual 2020
Pre-Congress Content
Multidrug-resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Incidence of cycloserine induced neurotoxicity in drug resistant TB patients attending a tertiary care hospital.
P. Singhal (Mumbai, India), P. Lunia (Mumbai, India), K. Salgia (Mumbai, India), I. Syed (Mumbai, India)
Source:
Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session:
Multidrug-resistant tuberculosis
Session type:
E-poster session
Number:
1593
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Singhal (Mumbai, India), P. Lunia (Mumbai, India), K. Salgia (Mumbai, India), I. Syed (Mumbai, India). Incidence of cycloserine induced neurotoxicity in drug resistant TB patients attending a tertiary care hospital.. 1593
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Treatment outcome of multi-drug resistant tuberculosis treated as outpatient in a tertiary care center
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011
Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai.
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Study of sputum conversion in drug resistant tuberculosis patients attending a tertiary care centre in navi mumbai
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Multi drug resistant tuberculosis in a tertiary university hospital
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Antituberculosis drug resistance in a secondary care hospital in Turkey
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
Pattern of drug resistance in TB patients treated at DR TB unit in tertiary care public sector hospital in Karachi Pakistan
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Clinical characteristics and antibiotic prescribing in patients admitted with community acquired pneumonia to a university hospital in Pakistan
Source: Eur Respir J 2004; 24: Suppl. 48, 242s
Year: 2004
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Prescription of antibiotics for the treatment of community acquired pneumonia in a district general hospital in the UK
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis
Year: 2008
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Prevalence of depression in tuberculosis patients in comparison to non-tuberculous family contacts visiting the DOTS Clinic in tertiary care hospital and its correlation with disease pattern
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Isoniazid plasma concentration monitoring in patients with pulmonary tuberculosis at a teaching referral hospital
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Pattern of drug resistance and treatment outcome of pulmonary tuberculosis treated at a tertiary care tuberculosis center in India- A retrospective analysis
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Treatment of latent tuberculosis infection among healthcare workers at a tertiary hospital in Korea
Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity
Year: 2018
Burden of co-morbid conditions in TB patients attending a tertiary care hospital in India
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept